OctaSodium (1S,2R,3S,4S,5S,6S)-3,5-dihydroxy-2,4,6-tris(phosphonatooxy)cyclohexyl phosphate

Catalog No. :
ACIDAL751
CAS No. :
210488-61-2
Molecular Formula :
C6H8Na8O18P4
Molecular Weight :
675.93

IUPAC Name:sodium (1R,2S,3S,4S,5S,6S)-4,6-dihydroxycyclohexane-1,2,3,5-tetrayl tetrakis(phosphate)

OctaSodium (1S,2R,3S,4S,5S,6S)-3,5-dihydroxy-2,4,6-tris(phosphonatooxy)cyclohexyl phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameOctaSodium (1S,2R,3S,4S,5S,6S)-3,5-dihydroxy-2,4,6-tris(phosphonatooxy)cyclohexyl phosphate
IUPAC Namesodium (1R,2S,3S,4S,5S,6S)-4,6-dihydroxycyclohexane-1,2,3,5-tetrayl tetrakis(phosphate)
Molecular FormulaC6H8Na8O18P4
Molecular Weight675.93
SMILES[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].O[C@H]1[C@@H](OP([O-])([O-])=O)[C@H](O)[C@@H](OP([O-])([O-])=O)[C@H](OP([O-])([O-])=O)[C@H]1OP([O-])([O-])=O
InChI KeyQYQMPPDYTHNACQ-ZOJXHACUSA-F
SynonymD-MYO-INOSITOL-1,3,4,5-TETRAKIS(DIHYDROGEN PHOSPHATE), OCTASODIUM SALT;D-MYO-INOSITOL-1,3,4,5-TETRAPHOSPHATE SODIUM SALT;INS(1,3,4,5)P4 (NA+ SALT);INS(1,3,4,5)IP4 (SODIUM SALT);1D-MYO-INOSITOL-1,3,4,5-TETRAKISPHOSPHATE, (NA+ SALT);D-myo-Inositol-1,3,4,5-tetrakis(phosphate) octasodium salt;QYQMPPDYTHNACQ-ZOJXHACUSA-F;[(1R,2S,4S,5S)-2,4-dihydroxy-3,5,6-triphosphonatooxycyclohexyl] phosphate
CAS No.210488-61-2

Synthetic Route by SureRoute

1. ACIDAL751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIDAL751 route product structure diagram
    ACIDAL751210488-61-2
Inquiry

2. ACIDAL751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIDAL751 route product structure diagram
    ACIDAL751210488-61-2
Inquiry

Comments (0)